Benton Susan 4
4 · Ocuphire Pharma, Inc. · Filed Sep 3, 2021
Insider Transaction Report
Form 4
Benton Susan
Director
Transactions
- Purchase
Common Stock
2021-09-02$4.57/sh+20,000$91,400→ 23,976 total
Footnotes (1)
- [F1]The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $4.52 to $4.61. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.